語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Cancer vaccines
~
Ottensmeier, Christian.
Cancer vaccines
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Cancer vaccinesedited by Natalia Savelyeva, Christian Ottensmeier.
其他作者:
Savelyeva, Natalia.
出版者:
Cham :Springer International Publishing :2017.
面頁冊數:
vii, 210 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
標題:
CancerVaccination.
電子資源:
http://dx.doi.org/10.1007/978-3-319-23910-1
ISBN:
9783319239101$q(electronic bk.)
Cancer vaccines
Cancer vaccines
[electronic resource] /edited by Natalia Savelyeva, Christian Ottensmeier. - Cham :Springer International Publishing :2017. - vii, 210 p. :ill., digital ;24 cm. - Current topics in microbiology and immunology,v.4050070-217X ;. - Current topics in microbiology and immunology ;v.351..
New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines - Messages that prevail -- The Use of Anti-CD40 mAb in Cancer.
This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment. This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.
ISBN: 9783319239101$q(electronic bk.)
Standard No.: 10.1007/978-3-319-23910-1doiSubjects--Topical Terms:
789097
Cancer
--Vaccination.
LC Class. No.: RC271.I45
Dewey Class. No.: 616.9940655
Cancer vaccines
LDR
:02496nmm a2200325 a 4500
001
520050
003
DE-He213
005
20170710183104.0
006
m d
007
cr nn 008maaau
008
180425s2017 gw s 0 eng d
020
$a
9783319239101$q(electronic bk.)
020
$a
9783319239095$q(paper)
024
7
$a
10.1007/978-3-319-23910-1
$2
doi
035
$a
978-3-319-23910-1
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC271.I45
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.9940655
$2
23
090
$a
RC271.I45
$b
C215 2017
245
0 0
$a
Cancer vaccines
$h
[electronic resource] /
$c
edited by Natalia Savelyeva, Christian Ottensmeier.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2017.
300
$a
vii, 210 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Current topics in microbiology and immunology,
$x
0070-217X ;
$v
v.405
505
0
$a
New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines - Messages that prevail -- The Use of Anti-CD40 mAb in Cancer.
520
$a
This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment. This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.
650
0
$a
Cancer
$x
Vaccination.
$3
789097
650
1 4
$a
Biomedicine.
$3
273648
650
2 4
$a
Cancer Research.
$3
273660
650
2 4
$a
Immunology.
$3
189152
650
2 4
$a
Vaccine.
$3
337782
700
1
$a
Savelyeva, Natalia.
$3
789095
700
1
$a
Ottensmeier, Christian.
$3
789096
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
830
0
$a
Current topics in microbiology and immunology ;
$v
v.351.
$3
557512
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-23910-1
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000145744
電子館藏
1圖書
電子書
EB RC271.I45 C215 2017
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-319-23910-1
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入